Findings from the individualized management of a patient with Acyl-CoA Oxidase-1 (ACOX1) deficiency: A bedside-to-bench-to-bedside strategy
- 28 September 2024
- journal article
- research article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 143 (3) , 108581
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Pharmacokinetic considerations for enhancing drug repurposing opportunities of anthelmintics: Niclosamide as a case studyBiomedicine & Pharmacotherapy, 2024
- SAR study of niclosamide derivatives for neuroprotective function in SH-SY5Y neuroblastomaBioorganic & Medicinal Chemistry Letters, 2023
- Serum fatty acid profiling in patients with SDHx mutations: New advances on cellular metabolism in SDH deficiencyBiochimie, 2022
- Evaluation of C26:0‐lysophosphatidylcholine and C26:0‐carnitine as diagnostic markers for Zellweger spectrum disordersJournal of Inherited Metabolic Disease, 2017
- A novel method for determining peroxisomal fatty acid β‐oxidationJournal of Inherited Metabolic Disease, 2016
- Peroxisomes: The neuropathological consequences of peroxisomal dysfunction in the developing brainThe International Journal of Biochemistry & Cell Biology, 2013
- Peroxisomal acyl‐CoA‐oxidase deficiency: Two new casesAmerican Journal of Medical Genetics Part A, 2008
- Clinical, biochemical, and mutational spectrum of peroxisomal acyl–coenzyme A oxidase deficiencyHuman Mutation, 2007
- Peroxisomal disorders: The single peroxisomal enzyme deficienciesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2006
- The biology and toxicology of molluscicides, bayluscidePharmacology & Therapeutics, 1982